190 related articles for article (PubMed ID: 19806245)
1. C-reactive protein and venous thromboembolism. A prospective investigation in the ARIC cohort.
Folsom AR; Lutsey PL; Astor BC; Cushman M
Thromb Haemost; 2009 Oct; 102(4):615-9. PubMed ID: 19806245
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal increases in blood biomarkers of inflammation or cardiovascular disease and the incidence of venous thromboembolism.
Folsom AR; Lutsey PL; Heckbert SR; Poudel K; Basu S; Hoogeveen RC; Cushman M; Ballantyne CM
J Thromb Haemost; 2018 Oct; 16(10):1964-1972. PubMed ID: 30007116
[TBL] [Abstract][Full Text] [Related]
3. Serum C-reactive protein increases the risk of venous thromboembolism: a prospective study and meta-analysis of published prospective evidence.
Kunutsor SK; Seidu S; Blom AW; Khunti K; Laukkanen JA
Eur J Epidemiol; 2017 Aug; 32(8):657-667. PubMed ID: 28718029
[TBL] [Abstract][Full Text] [Related]
4. Serum albumin and risk of venous thromboembolism.
Folsom AR; Lutsey PL; Heckbert SR; Cushman M
Thromb Haemost; 2010 Jul; 104(1):100-4. PubMed ID: 20390234
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein, obesity, and the risk of arterial and venous thrombosis.
Horvei LD; Grimnes G; Hindberg K; Mathiesen EB; Njølstad I; Wilsgaard T; Brox J; Braekkan SK; Hansen JB
J Thromb Haemost; 2016 Aug; 14(8):1561-71. PubMed ID: 27208592
[TBL] [Abstract][Full Text] [Related]
6. Hemostatic factors, inflammatory markers, and risk of incident venous thromboembolism: The Multi-Ethnic Study of Atherosclerosis.
Evensen LH; Folsom AR; Pankow JS; Hansen JB; Allison MA; Cushman M; Lutsey PL
J Thromb Haemost; 2021 Jul; 19(7):1718-1728. PubMed ID: 33773045
[TBL] [Abstract][Full Text] [Related]
7. Inverse association between serum albumin and future risk of venous thromboembolism: interrelationship with high sensitivity C-reactive protein.
Kunutsor SK; Seidu S; Katechia DT; Laukkanen JA
Ann Med; 2018 May; 50(3):240-248. PubMed ID: 29448840
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study.
Folsom AR; Alonso A; George KM; Roetker NS; Tang W; Cushman M
Thromb Res; 2015 Oct; 136(4):781-5. PubMed ID: 26337932
[TBL] [Abstract][Full Text] [Related]
9. Serum 25-hydroxyvitamin D and risk of venous thromboembolism: the Atherosclerosis Risk in Communities (ARIC) Study.
Folsom AR; Roetker NS; Rosamond WD; Heckbert SR; Basu S; Cushman M; Lutsey PL
J Thromb Haemost; 2014 Sep; 12(9):1455-60. PubMed ID: 25039645
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein and risk of venous thromboembolism in the general population.
Zacho J; Tybjaerg-Hansen A; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1672-8. PubMed ID: 20466978
[TBL] [Abstract][Full Text] [Related]
11. Inflammation markers and incident venous thromboembolism: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort.
Olson NC; Cushman M; Lutsey PL; McClure LA; Judd S; Tracy RP; Folsom AR; Zakai NA
J Thromb Haemost; 2014 Dec; 12(12):1993-2001. PubMed ID: 25292154
[TBL] [Abstract][Full Text] [Related]
12. Thrombosis risk and survival in cancer patients with elevated C-reactive protein.
Kanz R; Vukovich T; Vormittag R; Dunkler D; Ay C; Thaler J; Haselböck J; Scheithauer W; Zielinski C; Pabinger I
J Thromb Haemost; 2011 Jan; 9(1):57-63. PubMed ID: 20874781
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP).
Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Dressler D; Seifried E; Lindhoff-Last E
Thromb Haemost; 2009 Oct; 102(4):668-75. PubMed ID: 19806251
[TBL] [Abstract][Full Text] [Related]
14. Serum C-reactive protein-to-albumin ratio may be a potential risk indicator for venous thromboembolism: Findings from a prospective cohort study.
Kunutsor SK; Kurl S; Voutilainen A; Laukkanen JA
Nutr Metab Cardiovasc Dis; 2023 Apr; 33(4):864-867. PubMed ID: 36740560
[TBL] [Abstract][Full Text] [Related]
15. Orthostatic Hypotension and Risk of Venous Thromboembolism in 2 Cohort Studies.
Bell EJ; Agarwal SK; Cushman M; Heckbert SR; Lutsey PL; Folsom AR
Am J Hypertens; 2016 May; 29(5):634-40. PubMed ID: 26306405
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Chambless LE; Myerson M; Wu KK; Sharrett AR; Boerwinkle E
Arch Intern Med; 2005 Nov; 165(21):2479-84. PubMed ID: 16314544
[TBL] [Abstract][Full Text] [Related]
17. Prospective Study of Endogenous Hormones and Incidence of Venous Thromboembolism: The Atherosclerosis Risk in Communities Study.
Roetker NS; MacLehose RF; Hoogeveen RC; Ballantyne CM; Basu S; Cushman M; Folsom AR
Thromb Haemost; 2018 Nov; 118(11):1940-1950. PubMed ID: 30296818
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study).
Hermida J; Lopez FL; Montes R; Matsushita K; Astor BC; Alonso A
Am J Cardiol; 2012 Jan; 109(1):95-9. PubMed ID: 21962993
[TBL] [Abstract][Full Text] [Related]
19. Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study.
Lutsey PL; Folsom AR; Heckbert SR; Cushman M
J Thromb Haemost; 2009 Oct; 7(10):1639-48. PubMed ID: 19656279
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein(a) is not associated with venous thromboembolism risk.
Kunutsor SK; Mäkikallio TH; Kauhanen J; Voutilainen A; Laukkanen JA
Scand Cardiovasc J; 2019 Jun; 53(3):125-132. PubMed ID: 31032650
[No Abstract] [Full Text] [Related]
[Next] [New Search]
